Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan.
Clin Breast Cancer
; 22(1): e1-e7, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1252588
ABSTRACT
BACKGROUND:
The coronavirus disease 2019 pandemic is a global public health event. Wuhan used to be the epicenter of China and finally controlled the outbreak through city lockdown and many other policies. However, the pandemic and the prevention strategies had a huge impact on the medical care procedures for patients with breast cancer, leading to the delay or interruption of anticancer therapies. PATIENTS ANDMETHODS:
To better serve patients with breast cancer under the premise of epidemic control, many strategies have been proposed and optimized in our center. One of the most important parts of these strategies is the promotion of telemedicine, including online consultation, online prescription, and drug mailing services.RESULTS:
In keeping with the city and hospital policies, we have also introduced stricter ward management policies and more precise care.CONCLUSION:
Here, we collected the diagnosis and treatment process of patients with breast cancer in our center during the coronavirus disease 2019 pandemic, which was found to be correlated to a reduction in chemotherapy-related myelosuppression and hepatic dysfunction, hoping to provide a reference for other cancer centers that may suffer from the similar situation.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
Clin Breast Cancer
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
J.clbc.2021.04.014
Similar
MEDLINE
...
LILACS
LIS